INTRODUCTION
Coagulase-negative staphylococci are among the most commonly isolated organisms in the clinical microbiology laboratory. The frequent isolation of coagulase-negative staphylococci from blood, other normally sterile body fluids, intravenous catheters, peritoneal dialysates, the various tissues presents a recurring interpretive challenge to both clinical microbiologists and clinicians. Due to their ubiquitous nature and relatively low virulence, coagulase-negative staphylococci long have been considered to be clinically insignificant contaminants when isolated from clinical specimens (26, 27, 42, 50, 59, 64, 95, 139, 140, 146 ; W. M. Dunne, Jr., and T. R. Franson, Clin. Microbiol. Newsl. 8:37-42, 1986 ). However, in recent years, coagulase-negative staphylococci have become increasingly recognized as important agents of nosocomial infection (25, 34, 50, 64, 67, 95, 107, 123, 129, 151, 162, 165, 166 ; Dunne and Franson, Clin. Microbiol. Newsl. 8: [37] [38] [39] [40] [41] [42] 1986 ). Their role as significant pathogens following ophthalmologic (14, 114) , neurologic (38, 72, 135, 168) , and cardiothoracic surgery (4, 7, 8, 20, 30, 50, 73, 82, 106) , in immunocompromised patients (64, 67, 75, 88, 141, 162, 166) , and in patients with prosthetic devices (3, *Corresponding author. 8, 9, 19, 20, 23, 30, 62, 75, 81, 82, 97, 120, 129, 141, 154) has been well established. Among them, Staphylococcus epidermidis is the most frequently isolated species, occurring in the majority of nosocomial bloodstream infections (25, 26, 42, 64, 76, 78, 107, 112, 123, 151) . The postulated reasons for the current prevalence and clinical importance of these organisms include their great numbers on the skin, their selection as a result of widespread usage of broad-spectrum antibiotics in the hospital, their ability to adhere to and form biofilms on the surfaces of vascular catheters and other medical devices, and their meager nutritional requirements.
Of particular concern is the rising incidence of bacteremia due to coagulase-negative staphylococci in association with the use of long-term indwelling central venous catheters; 18% of documented episodes of bacteremia associated with these devices have been attributed to these organisms (141, 162, 166) . The question as to whether infections of these and other implantable prosthetic devices can be successfully treated without removal remains a topic of debate with significant clinical and economic implications (35, 38, 64, 75, 95, 120, 129, 136, 141, 154, 162, 166, 168) . Thus, it has become increasingly important to distinguish between infective and noninfective isolates of coagulase-negative staphylococci as well as to identify phenotypic traits which may be predictive of therapeutic outcome (6, 8, 26, 35, 38, 76, 282 PFALLER AND HERWALDT 111, 113, 168) . Although no single determinant can be used to identify clinically significant isolates of coagulase-negative staphylococci, certain clinical, epidemiological, and microbiologic criteria should increase suspicion of true infection. The purpose of the present review is to provide a current summary of the microbiologic, clinical, and epidemiologic aspects of coagulase-negative staphylococci. In doing so, we will discuss the rationale and necessity for species identification, the newer identification and epidemiologic typing methods, antimicrobial susceptibility testing, mechanisms of pathogenesis, and prevention and therapy of coagulase-negative staphylococcal infections.
MICROBIOLOGY Classification
Staphylococci are members of the family Micrococcaceae. They are nonmotile, nonsporeforming, gram-positive, facultatively anaerobic, clustering cocci that produce catalase. The distinction between coagulase-negative staphylococci and micrococci is important since some species of coagulase-negative staphylococci are important opportunistic and nosocomial pathogens, whereas, at present, micrococci are considered harmless saprophytes. Staphylococcus species are delineated from Micrococcus species on the basis of (i) glucose fermentation (positive for most staphylococci and negative for most micrococci) (12, 43, 132) , (ii) acid production from glycerol (positive for most staphylococci and negative for most micrococci) (12, 89, 111) , (iii) susceptibility to lysostaphin (staphylococci) (12, 89, 111, 132) , (iv) susceptibility to lysozyme (micrococci) (12, 89, 132) , (v) modified oxidase and benzidine tests (negative in most staphylococci and positive in micrococci) (45) , (vi) susceptibility to furazolidine (staphylococci) (11, 12) , and (vii) susceptibility to bacitracin (micrococci) (44) . Finally, differences in peptidoglycan and teichoic acid composition and deoxyribonucleic acid (DNA) base composition provide a clear distinction between staphylococci and micrococci and confirm the results of the more simple tests listed above (12, (132) (133) (134) 144) . At present, there are 23 recognized species of staphylococci, 21 of which are coagulase negative, and 12 of them are found as part of the normal flora of humans (88-90, 110, 111, 132; W. E. Kloos, Clin. Microbiol. Newsl. 4:75-79, 1982) . The subgeneric structure and biochemical diversity of Staphylococcus is extremely complex and has been extensively discussed in several recent reviews (87, 90, 92, 110, 132 ; Kloos, Clin. Microbiol. Newsl. 4:75-79, 1982) .
Originally, of all the staphylococci, only Staphylococcus aureus was considered pathogenic and was delineated from the other species on the basis of coagulase production, mannitol fermentation, and the presence of protein A on the cell wall surface. All other species were grouped under the species designation S. albus, which was subsequently changed to S. epidermidis, and were considered nonpathogens (64, 89, 111 21 species are now recognized (Table 1) based on extensive morphological, physiological, and biochemical characters and cell wall peptidoglycan and teichoic acid composition. These relationships were subsequently confirmed by DNA-DNA hybridization and comparative immunological studies (1, 89, 90, 110, 111, [132] [133] [134] 144) . Based on this work, the genus Staphylococcus can be divided into several species groups ( Table 1 ). The S. epidermidis species group is the largest, containing S. epidermidis, S. haemolyticus, S. hominis, S. saccharolyticus, S. warneri, S. capitis, and S. caprae. The S. saprophyticus species group consists of S. saprophyticus, S. cohnii, and S. xylosus. The S. simulans species group is composed of S. simulans and S. carnosus, and the S. sciuri species group contains S. sciuri and S. lentus. S. auricularis is closely associated with the S. epidermidis species group, and S. arlettae, S. equorum, S.
gallinarum, and S. kloosii are associated with the S. saprophyticus species group. S. caseolyticus and S. hyicus cannot be accommodated in any of the species groups. Of the coagulase-positive staphylococci, S. aureus is closely associated with the S. epidermidis species group and S. intermedius cannot be accommodated in any of the existing species groups. Most of the coagulase-negative staphylococci are common inhabitants of the skin and mucous membranes. In studies of the ecology of staphylococci on human skin, Kloos and co-workers (87-90; Kloos, Clin. Microbiol. Newsl. 4:75-79, 1982) found that S. aureus and S. epidermidis were the predominant and persistent staphylococci isolated from the nares whereas S. epidermidis and S. hominis predominated on the skin of the axillae, head, legs, and arms. S. capitis was often isolated from the head, face, ear, and arms, S. auricularis was isolated from the ear, and S. haemolyticus was isolated from the head, legs, and arms. S. simulans, S. (89) .
Presently it is clear that, in addition to S. aureus, those staphylococci of documented clinical importance are S. epidermidis and S. saprophyticus. In studies that have attempted to correlate species identification with clinical significance, S. epidermidis has accounted for the majority (>75%) of the coagulase-negative staphylococcal isolates (9, 25, 26, 34-37, 50, 59, 76, 77, 82, 122, 124, 129, 140) . This is most likely due to the overwhelming preponderance of S. epidermidis on the skin (88) (89) (90) (91) 94) ; however, S. epidermidis may also possess virulence factors absent in other coagulase-negative staphylococci (9, 26, 27, 53, 55, 56, 98, 163 Newsl. 8:37-42, 1986 ). This can be accomplished on the basis of colony morphology, coagulase and phosphatase activities, acid production from D-mannitol, D-trehalose, maltose, sucrose, and D-xylose, and novobiocin susceptibility (89, 91, 92, 110, 132) . The identification of other species of coagulase-negative staphylococci can be accomplished with these tests plus the determination of acid production from certain additional carbohydrates and certain enzyme activities (89, 91, 92, 110, 132 [37] [38] [39] [40] [41] [42] 1986) , there are several positive reasons to encourage more widespread species identification of these organisms. In addition to the value of having an exact etiological diagnosis, identification increases the knowledge of the pathogenicity of the various species of coagulase-negative staphylococci, provides useful epidemiologic information, and contributes to the predictive value of an isolate being of clinical significance versus being a contaminant (6, 26, 35, 76) . The results of Ishak et al. (76) demonstrate that knowledge of the species of coagulasenegative staphylococci and its ability to produce slime may assist the clinician in evaluating the clinical significance of such an isolate growing from a blood culture. They found that the isolation of S. epidermidis sensu stricto from blood, particularly if it was slime positive, was highly predictive of clinical infection whereas the isolation of any other species of coagulase-negative staphylococci was not (76) . Similarly, Archer et al. (6) demonstrated that delineation of individual strains, as well as species, of coagulase-negative staphylococci may be useful in distinguishing infective versus noninfective isolates for diagnostic purposes and as an epidemiologic tool for investigating infections.
The commercial availability of rapid and miniaturized identification systems provides virtually every clinical laboratory with the capability of identifying coagulase-negative staphylococci to the species level. Several manufacturers of commercial kit identification systems or automated instruments have products that are relatively simple and rapid and allow the identification of coagulase-negative staphylococcal species with an accuracy of 70 to >90% when combined with coagulase testing and novobiocin susceptibility (2, 39, 55, 58, 61, 75, 89, 92-94, 116, 130, 141) . The systems currently available are presented in Table 2 (7 of 23) . The major disadvantage of the system was that, for 112 (64%) of the isolates, the identification was not complete until after 48 h of incubation. The advantages of the system are that the plates can be read either visually or automatically with the autoSCAN-4 reader and that the panels also test for the minimal inhibitory concentrations of 12 antibiotics. The simultaneous determination of both "biotype" and "antibiogram" may be useful in delineating specific strains of coagulase-negative staphylococci for clinical and epidemiologic purposes (26, 168 (60) . Thus, the proportion of phosphatase-negative S. epidermidis isolates included in an evaluation of this system may markedly influence the overall results of the evaluation. The difficulty in the identification of phosphatase-negative S. epidermidis by the Staph-Ident System has been noted oy several investigators (32, 39, 57, 74, 168 (91) . The Minitek system correctly identified 96% of the S. epidermidis isolates in this study. The Minitek errors most commonly involved the misidentification of S. warneri (60% misidentified) or S. hominis (60% misidentified); however, each of the misidentifications was due to a number of incorrect reactions and was not the result of any consistent error. The Minitek system compares favorably with several of the commercially available staphylococcal identification systems and appears to be a practical, reliable method for species identification of coagulase-negative staphylococci. One advantage of the Minitek system is its flexibility. Different tests can be performed by adding or changing the types of biochemical disks, and the same methodology can be used to identify certain gram-negative bacilli, Neisseria species, and yeasts. Additional studies with different substrates may enlarge or enhance the data base with resulting improved accuracy for species identification of coagulasenegative staphylococci.
Sceptor Gram-Positive MIC/ID. The Sceptor Gram-Positive MIC/ID panel is a microdilution system for-the combined susceptibility testing and identification of 11 species of Staphylococcus (10 coagulase negative), 7 species of Micrococcus, and 22 species of Streptococcus. The dehydrated panels have 24 wells designated for biochemical tests and the remainder designated for susceptibility tests. The Sceptor system is available as a manual or semiautomated system. The semiautomated system consists of an automated preparation station and a semiautomated reader-recorder. The preparation station automatically dispenses 100 ,ul of the inoculum suspension into each well of the microdilution panel in <1 min. The reader-recorder instrument facilitates the visual reading and manual recording of test results. The test inoculum for the Sceptor system is prepared by growing the test organism in broth at 350C to a density approximating a 0.5 McFarland standard, diluting this suspension 1:100, and inoculating the test panels. The panels are incubated at 350C for 18 to 24 h and then read visually. The Sceptor Gram-Positive MIC/ID panel was recently evaluated by Skulnick and co-workers (Abstr. Annu. Meet. Am. Soc.
Microbiol. 1987). The Sceptor system correctly identified 91% of 115 clinically significant isolates of coagulase-negative staphylococci which had previously been identified by the method of Kloos and Schleifer (91) . Overall, 4 of the 10 misidentifications with the Sceptor system were due to failure of the data base to recognize lactose-variable S. haemolyticus. The performance of the Sceptor system was comparable to that of several other staphylococcal identification systems, and the accuracy may be improved by minor alterations to the existing data base. Similar to the MicroScan system described above, the simultaneous determination of biotype and antibiogram with the Sceptor system may be advantageous.
Vitek GPI Card. The Vitek AutoMicrobic System utilizes a GPI card to identify staphylococci, streptococci, and certain other gram-positive bacteria. The GPI card contains 27 biochemical wells and 1 positive and 2 negative growth control wells. In addition, a Gram stain, catalase test, coagulase test, and hemolysis results (beta versus non-beta) are required for the accurate performance of the GPI card. The inoculum suspension equivalent to a 0.5 McFarland standard is prepared in 0.45% saline and inoculated into the GPI card with a transfer tube and the filling module of the AutoMicrobic System. During incubation in the readerincubator module, the computer automatically analyzes the reactions of the GPI card, and the identification is automatically printed out from the data terminal. The incubation period for the GPI card varies according to the growth rate of the inoculated organism. Identification for most staphylococci will be made after incubation for 4 to 13 h (average, 10.8 h). Currently, the published studies of the GPI card have used a card and software capable of identifying only S. epidermidis, S. saprophyticus, S. hominis, S. haemolyticus, S. simulans, and S. aureus (Table 2) (2, 60, 128) . Recently, the data base for the GPI card has been expanded to allow the identification of up to 12 species of coagulase-negative staphylococci plus S. aureus, S. intermedius, and S. hyicus (coagulase positive); however, evaluations of the expanded data base have not been published, and thus the present discussion is limited to evaluation of the old GPI card and data base. Published evaluations indicate that the GPI card correctly identifies between 67 and 83% of coagulase-negative staphylococcal isolates. In an early study, Ruoff et al. (128) reported that the GPI card correctly identified 79% of 98 coagulase-negative staphylococci, including 88% of S. epidermidis and 100% of S. saprophyticus. Almeida et al. (2) found that the GPI card was only 67.3% accurate in identifying 150 clinical coagulase-negative staphylococci isolates. The GPI card was most accurate in identifying S. epidermidis (95% correct) and S. saprophyticus (87.1% correct) and was least able to identify S. hominis (26.7% correct). In agreement with the findings of Ruoff et al. (128) , these investigators noted difficulty in correctly identifying the less commonly isolated species by the GPI card. Those species not included in the data base were assigned an incorrect species designation instead of being included under Staphylococcus species. Finally, Grasmick et al. (60) reported that the GPI card correctly identified 83.2% of 190 coagulasenegative staphylococcal isolates and 95.9% of 145 S. epidermidis isolates. Based on these studies, the advantages of the Vitek GPI system are (i) automated reading and interpretation, (ii) rapid time to identification, and (iii) small inoculum requirement. The disadvantages are (i) limited data base (expanded in the most recent version of the GPI card) and (ii) requirement for expensive instrumentation which may also take up extra laboratory space. It is apparent from the preceding discussion that there are several commercially available systems for rapid and convenient species identification of clinical isolates of coagulasenegative staphylococci. Although the accuracy of these systems varies considerably between the published studies, in general they are all quite accurate in identifying S. epidermidis and S. saprophyticus, the two most important coagulase-negative staphylococcal pathogens. Although the need for identifying most clinical isolates of coagulasenegative staphylococci to species remains controversial, the availability of these identification systems will facilitate further investigative efforts in this area (95, 111, 139) .
Epidemiological Typing Systems
As noted above, coagulase-negative staphylococci are universally found on human skin and several species can be detected on any given individual; however, S. epidermidis sensu stricto is the most common species isolated in the clinical laboratory. When a species that appears to be the cause of infection is a frequent or universal member of the normal flora or the environment, simple species identification is no longer useful in distinguishing between infection and colonization or in tracing the source of the infecting organism. The ubiquitous nature of S. epidermidis and its expanding role as a major nosocomial pathogen has necessitated the development of methods of strain delineation within species for use as epidemiological and diagnostic tools. The rationale for strain delineation is that repeated isolation of an organism with identical markers from one or more patients suggests that the organism has originated from a single clone and therefore is highly likely to be causing infection (individual patient) or has been transmitted from patient to patient from a common source or by a common mechanism or both. Several different epidemiological typing methods have been applied in studies of coagulase-negative staphylococci. These include antimicrobial susceptibility profiles (antibiogram), biochemical profiles (biotype), serological typing, bacteriophage susceptibility patterns (phage typing), and DNA typing methods (plasmid profiling, restriction endonuclease analysis of plasmid and chromosomal DNA, and DNA hybridization). The timely delineation of specific phenotypic (or genotypic) profiles of coagulasenegative staphylococci by one or more of the above methods will provide the basis for studies designed to answer important epidemiologic and pathogenetic questions, including (i) the site of origin (reservoir) of organisms causing nosocomial infections, (ii) the frequency and mechanism of patient-topatient or hospital staff-to-patient spread of coagulase-negative staphylococcal isolates causing nosocomial infection, and (iii) the importance of strain variation in the pathogenesis of coagulase-negative staphylococcal infection. In addition, in individual patients such data will be useful in providing evidence that separate clinical isolates are identical and thus likely to be true pathogens rather than contaminants (6, 26, 35, 76, 111, 112) . It is important to emphasize that our knowledge concerning the origins, reservoirs, and modes of transmission of coagulase-negative staphylococci is extremely limited and that the application of epidemiologic typing methods is essential in answering these questions. The information gained from studies that use useful typing methods will result in improved methods of prevention, diagnosis, and therapy, as well as increased understanding of the pathogenesis of coagulase-negative staphylococcal infections. The utilization of these typing methods to study these organisms has recently been reviewed in detail by Parisi (111, 112) ; thus, only selected aspects will be discussed below.
Antibiogram. The antimicrobial susceptibility profile or antibiogram has been used extensively to distinguish strains of various organisms, including clinical isolates of coagulasenegative staphylococci (9, 25, 26, 50, 64, 73, 100, 106, 111, 168) . In a study of nosocomial bloodstream isolates, Christensen et al. (26) reported that biotyping alone with the Staph-Ident system could not reliably delineate strains of S. epidermidis (assignment probability, P = 0.346) but that the combination of biotype plus the antibiogram greatly enhanced the discriminating power of both systems (assignment probability P = 0.037). Mickelsen et al. (106) found that the biotypes obtained with the Staph-Ident system were not reproducible because each of five isolates of S. epidermidis gave a different biocode when tested on two different occasions. Others have reported similar limitations to the use of these systems alone in epidemiologic studies (39, 111, 114, 168) . Of particular interest with regard to biotyping coagulase-negative staphylococci is the recent report of Younger et al. (168) that phosphatase-negative strains of S. epidermidis may be a particularly virulent type of coagulasenegative staphylococci. They found that 20% of their cerebrospinal fluid shunt pathogens and none of the contaminants belonged to this subgroup. The pathogenic importance of this subgroup may have been obscured in the past due to the misidentification of phosphatase-negative S. epidermidis as S. hominis by the API Staph-Ident system. Additional studies of isolates from other sites of infection and from other institutions are warranted to confirm this important observation.
Serological typing. Serological typing has been useful as an epidemiological tool in the investigation of a variety of infectious diseases; however, it has not been well developed for use with coagulase-negative staphylococci (1, 111, 117, 132, 134, 155) . As might be expected, this is largely due to the difficulties of preparing specific antisera and the standardization of typing methods. Although S. aureus and S. epidermidis clearly share several group antigens, crossabsorption studies have demonstrated that S. epidermidis has its own set of type agglutinogens (1, 132, 134, 155) . This information has allowed for the development of typing sera, and serotyping, in combination with biotyping, has been applied successfully in a limited number of studies (117, 132, 134, 155) . Given the availability of other typing systems for coagulase-negative staphylococci, serotyping does not appear to have much of a role in epidemiological studies of these organisms.
Phage typing. The most established system for epidemiological typing of staphylococci is the determination of bacteriophage susceptibility patterns (phage typing). Although an international set of typing phages has been established for S. aureus, the application of this set to S. epidermidis was disappointing as these organisms were rarely lysed by phages isolated from S. aureus (111, 112 (115, 145, 152) . These typing sets have been widely used for strain identification either alone or in combination with other methods with varying degrees of success (26, 37, 50, 73, 106, 111, 112, 114, 152) .
Parisi (111) has described three characteristics that a phage-typing system should possess to be useful in epidemiological studies (i) It should type or lyse a large proportion of the strains. (ii) It should be reproducible; different isolates derived from the same bacterial clone should give essentially identical reactions. (iii) It should discriminate epidemiologically related strains from unrelated strains. An international collaborative study was performed to assess the existing coagulase-negative staphylococcal phage-typing systems with regard to the above characteristics. Four hundred isolates of S. epidermidis from serious infections, representing a minimum of 271 independent strains, were tested by 12 laboratories for susceptibility in their phage-typing systems (37 (26) demonstrated that phage typing alone was a poor strain discriminator (assignment probability P = 0.356) in a nonepidemic situation, but when combined with the antibiogram and biotyping it provided adequate discrimination between strains (assignment probability P = 0.015). They suggested that possibly phage typing of coagulasenegative staphylococci is better reserved for epidemic rather than endemic situations.
Molecular typing. The application of molecular typing, including plasmid pattern analysis, restriction endonuclease analysis of plasmid and chromosomal DNA, and DNA hybridization, is proving to be a promising means of identifying strains or a clonal population of staphylococci (6, 41, 66, 106, 111, 112, 114, 130, 161) . Plasmid analysis is now available in a number of clinical microbiology laboratories and provides a rapid method of characterizing bacterial isolates. Several features of plasmid analysis make it especially appealing in the study of coagulase-negative staphylococci. (i) The ease with which plasmids can be detected by gel electrophoresis from crude bacterial lysates puts plasmid analysis well within the capabilities of many clinical laboratories (6, 16, 66, 105, 106, 161) . (ii) A high percentage of coagulase-negative staphylococci (90% of S. epidermidis) have at least one and frequently multiple plasmids. Therefore, each strain produces a characteristic profile made up of its distinct plasmids (6, 106, 113, 114) . Comparison of these profiles from different isolates from the same patient or from different patients in an endemic or epidemic situation will help define the epidemiology of coagulase-negative staphylococcal infections. (iii) Further identification of individual plasmids can be achieved by restriction endonuclease treatment of the plasmids followed by gel electrophoresis. Two plasmids of identical sizes can be judged to be identical or different based on their restriction fragment patterns (66, 111, 112, 161) . (iv) Plasmid analysis has been shown to be a useful tool in evaluating a number of clinical situations including septicemias (6, 113) , differentiating contaminants from organisms responsible for prosthetic valve endocarditis, intravenous catheter sepsis, urinary tract infections, and osteomyelitis (66, 106, 111, 112, 114, 161 Subsequently, Archer and co-workers (6) have demonstrated the great diversity of plasmid patterns, and therefore strains of S. epidermidis, among isolates from different patients, from the same site on a given patient at different sampling times, and from different sites on a given patient at the same sampling time. Similar to previous studies, which demonstrated that surgery and antibiotic prophylaxis promoted colonization with antibiotic-resistant strains of coagulase-negative staphylococci (4, 7), they showed that skin cultures taken after surgery yielded isolates with plasmid patterns different from those taken before surgery.
Despite the many advantages of plasmid pattern analysis, the use of this technique to determine whether two isolates of coagulase-negative staphylococci are identical is not without shortcomings (6, 66, 106, 111, 112, 114) . (i) Technical factors such as variations in the plasmid extraction methods which may convert one molecular form of the plasmid to another or in the conditions of electrophoresis can all influence the final profile (6, 66, 106, 111) . (ii) Strains may lose antibiotic resistance plasmids or cryptic plasmids (106, 111, 112) . (iii) The ability to distinguish between two isolates decreases directly with the number of bands present and the diminishing difference in molecular size between two bands (6, 111) . (iv) Conjugal transfer of plasmids within or between species of staphylococci can lead to differences in plasmid patterns (5, 47, 58, 78, 130, 131, 153) . Mickelsen et al. (106) observed that epidemiologically related strains of S. epidermidis may differ by as many as three plasmids. They found that, despite the lack of complete identity of all isolates, a conserved core of several plasmids of identical molecular weight enabled them to recognize the relatedness of isolates from the same as well as from different patients. They suggested that additional experience is needed with isolates that are well defined epidemiologically, phenotypically, and genotypically to define the limitations of plasmid pattern analysis as an epidemiological tool. Likewise, Parisi et al. (114) noted occasional minor differences in plasmid pattern among isolates of S. epidermidis which were otherwise identical by phenotypical and epidemiological criteria. They suggest that, although plasmid pattern analysis is a very powerful epidemiological tool, a combination of methods (specifically, plasmid profiling plus phage typing) may provide the most useful epidemiologic data.
The techniques of restriction endonuclease analysis and DNA hybridization provide additional information on the nucleotide sequence within the plasmid and make it possible to confirm the identity between plasmids with a high degree of confidence. Restriction endonucleases are enzymes that recognize specific, palindromic base sequences and cleave those sequences at a defined position. No two different plasmids should have the identical restriction sites at identical intervals along the plasmid DNA. Thus, two plasmids with identical products or "fingerprints" after digestion with these enzymes are likely to be identical. Cutting plasmids with these enzymes adds about an hour to the plasmid isolation procedure and does not significantly affect the cost. Restriction endonuclease analysis can be used to type organisms not containing plasmids. Chromosomal DNA can also be digested by restriction endonucleases, resulting in unique reproducible electrophoretic gel patterns (66, 161 (99, 112, 149, 161) . By taking advantage of the fidelity of base pairings, one can unequivocally establish that two plasmids are identical by using a DNA fragment or an entire plasmid from one of the strains as a labeled probe in a Southern hybridization assay (149) . This technique has been used by Parisi (112) to confirm the transmission of a strain of S. epidermidis from a surgeon to two patients following coronary artery bypass surgery. Although primarily a research tool, this technique may see increasing application in epidemiologic studies due to its power and flexibility.
Slime production. Slime production by coagulase-negative staphylococci has been associated with the ability of these organisms to adhere to the surfaces of catheters and other plastic biomedical devices (27-29, 62, 118, 120, 143) . Although of primary interest in the pathogenesis of coagulasenegative staphylococcal infections (see below), this property has also been found by several investigators to be an efficient discriminator between infective and noninfective strains of S. epidermidis (9, 25, 29, 35, 38, 76, 168) . Recent evidence suggests that phenotypic variation in slime production may occur in some strains of S. epidermidis (24) ; however, the extent and significance of this variability is unclear, and slime production is generally considered to be a stable phenotypic trait (26, 27, 35, 38, 76) . Christensen et al. (26, 27) described a test for slime production which, although nonstandardized, has been used by several investigators to study the clinical significance of slime-positive and slimenegative coagulase-negative staphylococci (35, 38, 40, 76, 93, 108) . The slime test is performed by inoculating a loopful of organisms from the surface of a blood agar plate into a polystyrene tube containing 5 to 10 ml of tryptic soy broth and incubating at 35 to 37TC for 24 to 48 h. The contents of the tubes are then aspirated, washed with distilled water, and stained with either alcian blue or safranin. Slime production is judged to have occurred if a visible film lines the wall of the tube. Formation of a ring at the liquid-air interface is not considered indicative of slime production. Very little comparative data exist describing the effects of variation in the test procedure on slime production. Christensen et al. (27) reported that slime production in vitro requires both glucose and casein digests for expression. They found that many commonly used laboratory media such as brain heart infusion, Todd-Hewitt, brucella, MuellerHinton, nutrient, tryptone, and sucrose broths do not support slime production. Although there does not appear to be a significant difference between polystyrene and glass, polypropylene is not optimal as a substrate for the demonstration of the slime layer on the walls of the tubes (27, 29) .
The reproducibility of the slime test has been analyzed in three independent studies (29, 35, 38) . Davenport et al. (35) and Diaz-Mitoma et al. (38) both found the intra-assay, interassay, and interobserver reproducibilities of the slime test to be excellent, ranging form 90 to 100% (kappa = 0.9 to 1.0; P < 0.001). In contrast, Christensen et al. (29) noted variability between observers in interpreting tests of weakly positive strains of coagulase-negative staphylococci. This may be accounted for by the subjective and qualitative nature of the test, an obvious limitation. Quantitative assays for both slime production and adherence of coagulasenegative staphylococci to plastic have been developed to provide a more objective means to assess this important phenotypic characteristic (29, 121a) . These tests will facili-CLIN. MICROBIOL. REV. on August 27, 2017 by guest http://cmr.asm.org/ Downloaded from COAGULASE-NEGATIVE STAPHYLOCOCCI 289 tate comparison of slime production by different strains and species of these organisms and perhaps will serve as the basis for development of a more standardized assay for slime production.
The clinical and epidemiological usefulness of the slime test was first described by Christensen and co-workers (25) (26) (27) (28) (29) . These investigators demonstrated that, when used in combination with the antibiogram and the API Staph-Ident, slime production had a very high discriminatory power for delineating individual strains of S. epidermidis (26) . They also found that the frequency of slime production was significantly higher (63%) in strains associated with clinical signs of intravascular catheter-associated sepsis than in strains not associated with signs of infection (37%) (27) . These findings suggested that testing isolates for slime production, either alone or in combination with other phenotypic markers, may provide a simple method of distinguishing true pathogens from clinically insignificant isolates of coagulase-negative staphylococci. These studies were potentially limited by the fact that the isolates of coagulasenegative staphylococci were collected during an epidemic of catheter-related sepsis (25, 27 (76) found that, whereas the isolation of S. epidermidis from blood gave a positive predictive value for clinical infection of 67%, the determination that the isolate was also slime positive increased the positive predictive value to 87%. These results suggest that knowledge of the species of coagulase-negative staphylococci and its ability to produce slime may aid the clinician and clinical microbiologist in evaluating the clinical significance of such an isolate growing from a blood culture.
Despite the enthusiasm of the previously mentioned authors for slime production as a marker of infection, other investigators have found that slime production is not a universal feature of those strains causing infection (38, (47, 78, 130, 131, 153) have demonstrated conjugative transfer of gentamicin resistance plasmids from coagulase-negative staphylococci to coagulase-negative staphylococci and from coagulase-negative staphylococci to S. aureus. These data suggest that coagulase-negative staphylococci, particularly S. epidermidis, may be a reservoir for antibiotic resistance genes in the hospital environment. Future studies with DNA probes for antibiotic resistance genes of coagulase-negative staphylococci should help clarify this issue and provide a rational approach to control and spread of these resistance factors among hospital pathogens.
Several pitfalls in the performance of antimicrobial susceptibility testing of coagulase-negative staphylococci should be recognized and avoided. Resistance to penicillin is very common, particularly among hospital strains of coagulase-negative staphylococci, and is frequently mediated by a beta-lactamase-producing plasmid (3, 58) . Beta-lactamasemediated resistance to penicillin is frequently not detected by routine microdilution methods, and all isolates which appear susceptible to penicillin or ampicillin should be tested for beta-lactamase production (58) . The beta-lactamase enzyme in staphylococci is inducible and may not be fully expressed in all isolates; therefore, to avoid false-negative results, isolates must be exposed to an appropriate inducing agent, such as oxacillin, prior to beta-lactamase testing (58, 140) . Selepak and Witebsky (138) demonstrated that up to 60% of clinical isolates of coagulase-negative staphylococci would be misclassified as beta-lactamase negative if betalactamase testing were performed without prior induction. They recommend that the beta-lactamase tests be performed with induced organisms taken from the edge of the zone of inhibition around a 1-I±g oxacillin disk (58, 138) .
In contrast to penicillin resistance, resistance of staphylococci to methicillin and other penicillinase-resistant penicil-VOL. 1, 1988 on August 27, 2017 by guest http://cmr.asm.org/ Downloaded from 290 PFALLER AND HERWALDT lins (PRP) such as oxacillin and nafcillin is not mediated by beta-lactamase production, but rather is thought to be due, in part, to an altered penicillin-binding protein (PBP 2a or PBP 2') (22, 104, 157) . The association between PBP 2a (PBP 2') and resistance to the PRPs has been well established for S. aureus but until recently has not been clearly demonstrated for coagulase-negative staphylococci (22, 157) . The recent report of Chambers (22) convincingly demonstrates that methicillin resistance in coagulase-negative staphylococci and therapeutic failure with beta-lactam antibiotics in vivo are associated with the production of an altered PBP, PBP 2a, which is antibiotic inducible, has a low binding affinity for beta-lactam antibiotics, and is identical to PBP 2a (PBP 2') found in methicillin-resistant S. aureus.
Detection of coagulase-negative staphylococci which are resistant to the PRPs is a major problem because PRPresistant isolates are phenotypically heteroresistant to methicillin and the other PRPs (3, 65, 82; C. Thornsberry, Antimicrobic Newsl. 1: [43] [44] [45] [46] [47] 1984) . This means that, although each organism in a population may have the genetic information necessary for PRP resistance, only a small fraction (10-6 to 10-4) can actually express the PRP-resistant phenotype under in vitro testing conditions and thus may be easily missed when in vitro susceptibility testing is performed (3, 65, 82, 103, 104, 156; Thornsberry, Antimicrobic Newsl. 1: [43] [44] [45] [46] [47] 1984) . In vitro expression of the PRPresistant phenotype is favored by the presence of 2 to 5% NaCl in the medium, incubation temperatures of 30 to 350C and growth on agar rather than in broth medium (31, 50, 65; Thornsberry, Antimicrobic Newsl. 1: [43] [44] [45] [46] [47] 1984) . It appears, based on recent studies with S. aureus, that production of the altered PBP (PBP 2a or PBP 2') is stimulated at lower incubation temperatures (30 to 320C) and by NaCl (22, 96, 157) ; however, this has not been documented independently in coagulase-negative staphylococci. Thus, the expression of resistance as detected by in vitro testing methods is influenced by several factors, including inoculum size and preparation, time and temperature of incubation, and medium composition and osmolality (3, 31, 50, 65, 82, 103, 104, 156; Thornsberry, Antimicrobic Newsl. 1: [43] [44] [45] [46] [47] 1984) . Although there is a reasonable correlation between the effects of these various environmental factors on PBP 2a (PBP 2') production and expression of PRP resistance in staphylococci, it is likely that PBP 2a (PBP 2') production alone is not the entire explanation for PRP resistance (96, 157) . Regardless of the mechanism of PRP resistance, it is important to realize that routine susceptibility testing with methicillin, oxacillin, or nafcillin disks, automated turbidimetric systems, and microdilution systems may all yield false-susceptible results.
Several recommended modifications of the standard disk diffusion and broth dilution susceptibility methods improve detection of PRP-resistant strains of staphylococci (31, 50, 65, 103, 104, 156; Thornsberry, Antimicrobic Newsl. 1: [43] [44] [45] [46] [47] 1984) . Although initially optimized for the detection of PRP-resistant S. aureus, these methods have generally been shown to improve the detection of PRP-resistant coagulasenegative staphylococci (31, 50, 156, 167) . The current recommendations for optimal detection of PRP resistance are as follows. (i) The inoculum should be prepared by suspending organisms taken directly from an overnight (18-to 24-h) growth on an agar plate to the turbidity of a 0. (167) support most of the recommendations discussed above and offer additional recommendations specific for coagulasenegative staphylococci. Coudron et al. (31) reported that (i) prolonged incubation (>24 h) was usually not necessary to detect methicillin-resistant coagulase-negative staphylococci, (ii) methicillin was better than oxacillin for detecting methicillin-resistant S. epidermidis, and (iii) reliable alternative procedures for detecting methicillin-resistant coagulasenegative staphylococci include the spread plate and spot methods, using Mueller-Hinton agar supplemented with 4% NaCl and either methicillin (10 pug/ml) or oxacillin (6 ,ug/ml), and also the conventional disk diffusion method if salt (4% NaCl) is added to the medium and plates are read at 18 h. Woods et al. (167) recommend the use of a direct inoculum and either (i) a 24-h disk diffusion test with oxacillin (1 ,ug/ml) incubated at 35°C or (ii) an oxacillin agar screen (MuellerHinton agar supplemented with 4% NaCl and 6 ,ug of oxacillin per ml) incubated at 35°C for 24 h. In contrast to the above recommendations, they found prolonged (48- (25, 26, 42, 64, 76, 77, 107, 112, 123, 151) , and are associated with implanted prosthetic devices such as intravenous catheters, prosthetic heart valves, prosthetic joints, or central nervous system shunts (3, 8, 9, 19, 20, 23, 30, 62, 75, 81, 82, 97, 120, 129, 141, 154) . Colonization of foreign bodies by coagulasenegative staphylococci frequently leads to serious local and systemic disease. Bacteremia, endocarditis, mediastinitis, meningitis, and progressive joint destruction are all wellrecognized complications of prosthetic device infections due to coagulase-negative staphylococci (8, 18, 25, 30, 34, 38, 48, 50, 64, 67, 75, 81, 82, 84) .
Contrary to popular opinion, serious infection caused by coagulase-negative staphylococci is not a new phenomenon, although the incidence of such infections has clearly increased in recent years (25, 49, 151, 162, 166) . In a review published in 1958, Smith et al. (148) described a total of 90 cases of coagulase-negative staphylococcal septicemia reported in the literature between 1900 and 1955. In addition, they reported that 1.5% of staphylococcal bacteremias at the University of Iowa form 1936 and 1955 were caused by coagulase-negative staphylococci. The majority of these patients had "predisposing factors," the most common of which was previous rheumatic fever. Subsequently, Smith (147) (147) that the incidence of coagulase-negative staphylococcal septicemia was increasing. They found that from 1980 to 1987 it increased from 8 to 26% of all nosocomial bloodstream infections, and the infection rate increased from 5.2 to 38.6 cases per 10,000 admissions.
The findings reported from the University of Iowa are supported by data from many other institutions (25, 49, 151, 162, 166 1982 . They concluded that this represented neither an increase in the frequency of isolation of coagulase-positive staphylococci nor an increase in the frequency of obtaining blood cultures. Rather, they attributed it to a 62.3% increase in the neonatal intensive care unit bed use by infants with birth weights of <1,000 g. Positive blood cultures were 3.8 times more likely to be considered clinically significant in these infants than in those with higher birth weights. This study emphasizes the need for controlled studies evaluating both the incidence of and risk factors for coagulase-negative staphylococcal infections in hospitalized patients.
Although coagulase-negative staphylococci are generally considered to be of low virulence, the reported crude mortality rates associated with coagulase-negative staphylococcal bacteremia are quite high, ranging from 27 to 78% (25, 48, 123, 129, 147, 151 ; Dunne and Franson, Clin. Microbiol. Newsl. 8: [37] [38] [39] [40] [41] [42] 1986 ). Because many of these patients have serious underlying diseases, it is important to distinguish the mortality actually attributable to the nosocomial coagulasenegative staphylococcal bacteremia from that due to the underlying disease. Martin et al. (27th ICAAC) recently reported the results of a retrospective matched case control study in which the crude mortality in a group of 58 patients with coagulase-negative staphylococcal nosocomial bloodstream infection and their controls was 31 and 19%, respectively. In an effort to control for confounding variables such as severity of underlying diseases and other comorbid factors, the patients and controls were closely matched for age, sex, type and severity of underlying disease, and surgical procedures. One hundred percent of the patients and their VOL. 1, 1988 on August 27, 2017 by guest http://cmr.asm.org/ 292 PFALLER AND HERWALDT controls were matched for primary diagnosis, and 89% were matched for secondary diagnosis. To ensure that the control's duration of exposure to risk factors for coagulasenegative staphylococcal bacteremia was at least as long as that of the patient, controls were considered only if their total length of stay was greater than or equal to the time from admission to infection for the patient. The morality directly attributable to coagulase-negative staphylococcal bloodstream infection in this study was 12%. In addition, the median length of hospital stay for the patients was 55 days compared with 41 days for controls, yielding an excess length of stay of 14 days directly attributable to the infection. Thus, the increase in mortality directly attributable to coagulase-negative staphylococcal nosocomial bloodstream infection was substantial, and the increase in length of stay imposes a significant economic burden.
While sepsis is the most common manifestation of coagulase-negative staphylococcal infection, gastrointestinal (162) , pharyngeal (162, 166) , urinary tract (123, 166) , skin (123, 166) , and pulmonary (162, 166) infections have been documented. One major problem in the prevention and diagnosis of coagulase-negative staphylococcal infections in hospitalized patients is the difficulty in differentiating infection from colonization. The clinical signs and symptoms associated with both local and systemic coagulase-negative staphylococcal infections are well known, but are not specific, and may be masked in critically ill patients. Furthermore, cultures obtained from a variety of body sites are frequently confusing or misleading due to the propensity of these organisms to colonize.
Attempts to identify the reservoirs and the site of origin of the strains of coagulase-negative staphylococci causing nosocomial infections have been hampered by the inadequacies of epidemiologic typing systems and by the presence of multiple strains on each individual (23, 41, 111) . It is generally believed that coagulase-negative staphylococci colonizing the skin of the individual patient are the usual source of coagulase-negative staphylococcal bacteremia and prosthetic device infection (6, 9, 23, 25, 41, 64, 67 1036, 1987) have provided evidence to support the gastrointestinal tract as an important source for coagulase-negative staphylococcal bacteremia, and Parisi (112) has convincingly documented transmission of coagulase-negative staphylococci from hospital staff to patients. In addition, epidemiologic and microbiologic studies have suggested that coagulase-negative staphylococcal infections of cardiac or orthopedic prostheses may be initiated at the time of implantation with the flora of the patient, surgeon, or environmental isolates (48, 50, 73; Dunne and Franson, Clin. Microbiol. Newsl. 8:37-42, 1986) . Despite these studies, there are major deficiencies in our understanding of important factors relating to infection with coagulase-negative staphylococci. Very little is known concerning the significance and length of carriage of S. epidermidis or other species of coagulasenegative staphylococci by patients and hospital staff. Likewise, the reservoir of the infecting strains and the mechanism of transmission of coagulase-negative staphylococci within the hospital are poorly understood. Although differences in species, antibiogram, biotype, and plasmid pattern of coagulase-negative staphylococci causing infection and merely colonizing patients have been noted, these differences have not been fully exploited to differentiate strains for epidemiologic purposes and have not been incorporated into a unified explanation of the pathogenicity of the organisms.
PATHOGENESIS OF COAGULASE-NEGATIVE STAPHYLOCOCCAL INFECTIONS Host Factors
The emerging role of coagulase-negative staphylococci as important nosocomial pathogens has prompted increased interest in the pathogenesis of coagulase-negative staphylococcal infections. Host factors that often may lead to serious infections with coagulase-negative staphylococci are well characterized. These factors include breaches in natural mucocutaneous barriers due to trauma or inflammation (33, 50, 67, 73, 80, 83, 97, 102, 162, 166) , prior exposure to antibiotics (3, 4, 7, 25, 50, 83, 124, 136) , and immunosuppression (19, 46, 75, 83, 121, 160, 162, 166) . Patients with cancer and granulocytopenia appear to be a particularly high-risk group presumably due to the combined presence of granulocytopenia and mucosal damage and concurrent colonization of the alimentary tract by coagulase-negative staphylococci (75, 83, 162, 166) . Recent studies indicate that either systemic or localized opsonic deficiency may be a risk factor for coagulase-negative staphylococcal infection in neonates (46) and continuous ambulatory peritoneal dialysis patients (19, 85, 121, 160) respectively. In a study of continuous ambulatory peritoneal dialysis patients it was found that those with low opsonic activity in their peritoneal fluid had a 10-fold-greater incidence of peritonitis than those with a high opsonic activity (19, 85) . In addition, reduced numbers of peritoneal macrophages and intraleukocytic sequestration of viable coagulase-negative staphylococci may also be important in clinical continuous ambulatory peritoneal dialysis peritonitis (19, 121, 160) .
Although host defects are clearly important in the pathogenesis of coagulase-negative staphylococci infections, perhaps the most important factor contributing to the increasing number of nosocomial coagulase-negative staphylococcal infections is the presence of indwelling prosthetic devices in both compromised and noncompromised hosts. Thus serious (septic) infections caused by coagulase-negative staphylococci are most commonly associated with indwelling intravenous catheters, cardiac valve prostheses, prosthetic orthopedic devices, cerebrospinal fluid shunts, ventriculostomy drains, peritoneal dialysis catheters, and transvenous cardiac pacemakers (8, (25) (26) (27) (28) 30, 35, 62, 64, 67, 72, 75, 81, 82, 95, 97, 106, (118) (119) (120) 135, 141, 154, 166, 168; Dunne and Franson, Clin. Microbiol. Newsl. 8: [37] [38] [39] [40] [41] [42] 1986 ). The mechanisms by which coagulase-negative staphylococci gain access to the surfaces of the various prosthetic devices currently is a matter of debate and intense investigation. The source of the contaminating organism may be endogenous from the skin or mucosal (pulmonary or alimentary tract) surfaces of the patient or exogenous from the hospital environment or the hands of hospital personnel (4, 17, 25, 34, 40, 50, 73, 94, 97, 154, 162, 166 becomes colonized with these organisms secondary to exposure to the skin of the patient and to the hands of health care personnel performing catheter care and thus serves as the reservoir for the contaminating organism (23, 50, 94, 97, 154) . (iii) The microorganisms are introduced during the percutaneous or surgical implantation of the catheter, shunt, or cardiac or orthopedic prosthesis (20, 33, 50, 82, 97, 102, 141) . (iv) The organisms transiently enter the bloodstream or other normally sterile site from an endogenous source (pulmonary or alimentary tract) and subsequently colonize the implanted foreign device (20, 30, 50, 83, 97, 162) . Regardless of the mechanism, introduction of coagulase-negative staphylococci onto the surface of a prosthetic device may result in the formation of an adherent biofilm which then may serve as a persistent septic focus (9, 27, 28, 35, 38, 62, 76, 118-121, 142, 143, 154, 160, 168) . The presence of the foreign body may further compromise host defenses by creating a microenvironment which adversely affects opsonization and polymorphonuclear phagocytosis and bactericidal activity (19, 28, 62, 64, 120, 121, 143, 154, 160, 169 The initial rapid phase of hydrophobic attachment may be modulated by the interaction of organism and substrate with specific host proteins. Subsequent to or concomitant with initial attachment, specific adhesins and substratum receptors may interact if they are present in the particular biological system (62, 163) . Recent studies indicate that clinical isolates of coagulase-negative staphylococci bind fibronectin, collagen, and possibly other host proteins which form part of the glycoproteinaceous conditioning films that immediately coat prosthetic implants (62, 163) . Once attached to the surface of the implant a viscous extracellular polysaccharide substance or slime is produced which ultimately covers the bacteria completely, forming a biofilm on the surface of the implant (27, 62, 118-121, 154, 163, 168; Dunne and Franson, Clin. Microbiol. Newsl. 8:37-42, 1986 ). The exopolysaccharide slime of coagulase-negative staphylococci is not a true capsule but rather a loosely adherent amorphous material consisting of glucose, galactose, mannose, glycerol, hexosamine, phosphorous, glycine, alanine, and phenylalanine (62, 121) . The chemical composition may vary within and between species and may depend on the nutritional qualities of the environment. The slime material may function as an additional adhesin binding-to the surface of the implant and further consolidating adhesion, aggregation, and microcolony formation (62, (118) (119) (120) (121) .
The biofilm produced by the staphylococcal slime matrix on the surface of a prosthetic device provides a protective microenvironment within which optimal growth conditions are created and from which antagonistic environmental factors are excluded (62, (118) (119) (120) (121) 142) . The exopolysaccharide slime substance is believed to act as an ion-exchange resin for enhanced nutrition (62) and as a mechanical barrier to antibiotics (62, 121, 142) [37] [38] [39] [40] [41] [42] 1986 ). In addition to serving as a mechanical barrier, slime may interfere biochemically with coagulation (21) , neutrophil chemotaxis, and bactericidal activity (79, 109) , and other aspects of the cellular immune system (61, 121) .
In vitro studies have demonstrated enhanced adherence of slime-positive isolates of coagulase-negative staphylococci to catheters and have suggested that these strains may be uniquely adapted to adhere to smooth surfaces (27, 29, [37] [38] [39] [40] [41] [42] 1986 ). Slime-positive strains grow in vitro as a multilayered biofilm on the surface of intravascular catheters, whereas slime-negative strains do not (27, (118) (119) (120) (121) 142) . Transmission and scanning electron micrographs of intravascular catheters and endocardial pacemaker wires taken from patients with S. epidermidis sepsis document the formation of staphylococcal biofilms in vivo and provide evidence for the clinical importance of slime production by coagulase-negative staphylococci (120, 121) .
Recent animal studies have also suggested that slimepositive strains of S. epidermidis exhibit greater virulence in the presence of a foreign body (28) . Confirmation of the importance of slime production for human infections has been derived from several recent clinical studies (9, 25, 35, 38, 76, 168 (76) , and Davenport et al. (35) all demonstrate a significant association between the ability of an isolate to produce slime and its propensity to cause disease in patients with prosthetic devices. In addition, studies in our laboratory indicate that eradication of infection is more difficult when a slime-positive organism is involved (35) . The recent reports of Younger et al. (168) , Kristinsson et al. (93) , and Diaz-Mitoma et al. (38) provide additional evidence in support of the association between the ability of the infecting isolate to produce slime and bacteriologic treatment failure. The test for slime production employed in these studies may be a useful tool for managing patients with prosthetic device-related infections due to coagulase-negative staphylococci, to indicate whether antimicrobial therapy alone or in combination with prosthetic device removal is necessary (35, 38, 93, 168) . The data accumulated strongly suggest that slime production is an important factor in the colonization and infection of prosthetic devices; however, it is likely that slime production is only one of a number of important factors relating to the virulence of coagulase-negative staphylococci. The recent description of phenotypic variation in slime production by S. epidermidis (24) introduces an additional degree of complexity which must be addressed in future studies attempting to link slime production to pathogenesis.
Aside from the studies of the adherence properties of coagulase-negative staphylococci described above, little attention has been paid to other potential virulence factors of these organisms. Gemmell and co-workers (53, 55, 56) have evaluated the exoproteins of coagulase-negative staphylococci and their possible pathogenicity in infections of humans and animals. They found that coagulase-negative staphylococci produced a wide variety of potential toxins including hemolysins, cytotoxins, deoxyribonuclease, fibrinolysin, proteinase, and lipase-esterase (53, 55, 56) . Strong similarities were noted between the exoproteins produced by S. aureus, S. epidermidis, S. haemolyticus, and S. saprophyticus, suggesting that these exoproteins may be important virulence factors in infections of humans.
Although not generally considered a virulence factor, resistance to multiple antimicrobial agents clearly plays a role in the pathogenesis of nosocomial coagulase-negative staphylococcal infections. As mentioned previously, the majority of hospital strains of coagulase-negative staphylococci are resistant to multiple antibiotics. Organisms that resist conventional prophylactic therapy given for implant surgery may play a role in establishing infection. Coagulasenegative staphylococci have been shown to develop resistance rapidly to a wide variety of antibiotics and may serve as a reservoir for antibiotic resistance genes (3, 4, 5, 7, 47, 52, 78, 130, 131, 153) . Antimicrobial usage practices may select for multiresistant coagulase-negative staphylococci which colonize patients and staff who then serve as a hospital reservoir for antibiotic-resistant coagulase-negative staphylococci (3, 4, 7, 25, 63, 131, 153) .
THERAPY
The treatment of coagulase-negative staphylococcal infection is dependent on the severity and anatomic site of infection, the presence of a foreign body or prosthetic device, and the results of antimicrobial susceptibility testing. In general, if a foreign body is present, it must be removed to cure the infection (35, 38, 64, 82, 95, 119, 120 (82) have recommended that vancomycin be used empirically for the treatment of S. epidermidis infections, pending the results of accurate susceptibility testing. Furthermore, these investigators demonstrated that the addition of either rifampin or gentamicin enhanced the efficacy of vancomycin when used in the treatment of prosthetic valve endocarditis due to PRP-resistant S. epidermidis (82) . Alternative antibiotics are currently being investigated that may be useful against multiresistant isolates of coagulase-negative staphylococci. These include newer agents such as teichoplanin and the quinolone derivatives and older antibiotics such as coumeromycin, fosfomycin, fusidic acid, and novobiocin (13, 51, 64, 164) . Continued study of resistance mechanisms is essential to help predict and prevent the emergence of resistance to new as well as old antistaphylococcal agents.
PREVENTION
Frequent handwashing by all health care personnel is of primary importance in limiting staff-to-patient and patientto-patient spread of coagulase-negative staphylococci (20, 33, 73, 97, 127) . Limiting intraoperative bacterial contamination by meticulous surgical technique, proper preoperative skin preparation, and proper draping of the operative site are all important in minimizing the risk of surgical infections (33, 73, 102) . In addition, operating room staff with infections of the hands or arms should not be allowed to participate in surgical procedures no matter how minor the infections (20, 33, 102) . Strict attention to protocols for the insertion and management of intravenous and arterial catheters are clearly important in decreasing the risk of catheterrelated infections (97) . Daily surveillance of all intravascular lines and limiting the duration of placement of peripheral venous catheters to 72 h can greatly reduce the risk of catheter-related infections (97) . Because of the importance of adherence in coagulase-negative staphylococcal prosthetic device-related infections, several investigators have suggested that production of catheters and other implants which are resistant to bacterial adherence may be an effective means of preventing these infections (62, 64, 86, 116, 120, 139, 143 ; Dunne and Franson, Clin. Microbiol. Newsl. 8: [37] [38] [39] [40] [41] [42] 1986 ). Unfortunately, the antiadhesive surfaces of a variety of implants are neutralized by conditioning films, composed of host proteins and other materials, which immediately coat the surface of the device upon implantation (62) . Given that there is a "race for the surface" between tissue cell integration and microbial colonization of the implanted device, an alternative strategy for decreasing bacterial colonization might be to develop a biomaterial that is adhesive for the appropriate tissue cells and that encour-ages rapid eucaryotic colonization over bacterial colonization (62) . Use of prophylactic antibiotics during the vulnerable period before tissue integration of the implant surface and when the risk of random bacterial colonization is highest seems rational but is without any proven benefit and may, in fact, have significant adverse consequences (3, 4, 7, 34) .
The findings of Wade et al. (162) in granulocytopenic cancer patients suggests that the addition of vancomycin to the prophylactic oral nonabsorbable antibiotic regimen reduced alimentary tract colonization with coagulase-negative staphylococci and resulted in a decline in both bacteremic and nonbacteremic infections due to S. epidermidis. While this is encouraging, there are little, if any, additional data to support the routine use of prophylactic vancomycin in these patients.
Although the benefits of antistaphylococcal prophylaxis in cardiac and orthopedic surgery remain uncertain, it has become standard practice to use such prophylaxis (20, 68, 80) . The value of antimicrobial prophylaxis in cardiac surgery has never been tested in a placebo-controlled trial, and there is very little information available on infection rates in patients not receiving antibiotics. A study by Archer and Tenenbaum (7) demonstrated that widespread use of antibiotics for prophylaxis in cardiac surgery patients led to an increased prevalence of methicillin resistance in S. epidermidis isolates obtained from these patients. Furthermore, these investigators found that a high percentage of the methicillin-resistant postoperative isolates were also resistant to multiple antibiotics: penicillin, nafcillin, cephalosporins, and aminoglycosides (7) . Subsequently, Archer and Armstrong (4) found that cardiac surgery patients receiving a combination of rifampin and nafcillin prophylaxis became colonized with strains of S. epidermidis resistant not only to rifampin and nafcillin but also to gentamicin. The antibiotic resistance patterns shown by S. epidermidis isolates in these studies were similar to those found in isolates from cases of S. epidermidis prosthetic valve endocarditis in other studies (3) . Clearly antibiotic prophylaxis changed the coagulasenegative flora by selecting for multiply resistant strains capable of causing serious postoperative infections (3, 4, 7) . In addition, the organisms may serve as a reservoir of resistant strains which can be transferred from patient to staff, staff to patient, and among patients within the hospital (3-5, 7, 47, 52, 78, 129, 131, 153) . Thus, despite the increasing importance of coagulase-negative staphylococci as agents of nosocomial infection, it is not at all clear that antimicrobial prophylaxis is indicated or desirable. Certainly, further clinical and experimental studies are needed. Ideally, the prevention of coagulase-negative staphylococcal infections should be based on better understanding of the epidemiology, hospital reservoirs, mechanism of transmission, and host defenses against these organisms, particularly those associated with foreign devices.
